Skip to main content
Clinical Trials/IRCT20150101020514N25
IRCT20150101020514N25
Not Yet Recruiting
Phase 2

Clinical evaluation of the efficacy and safety of Luxiva brand skin mesotherapy solution for rejuvenation and improvement of facial skin elasticity and hydration

Atra Zist Arai Company0 sites20 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Atra Zist Arai Company
Enrollment
20
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Atra Zist Arai Company

Eligibility Criteria

Inclusion Criteria

  • Age between 35 and 60 years old
  • Present visible signs of skin ageing symptoms mainly skin dryness skin roughness, loss of elasticity and appearance of fine lines
  • Possibility to accompany the visit plans and study process.
  • Signing an informed consent form and agreed to follow up.

Exclusion Criteria

  • Previous treatment with hyaluronic acid fillers in the facial area within the past year
  • Experience with RF, rejuvenation lasers or intense pulsed light in the past 6 months
  • Systemic diseases affecting skin health such as collagen vascular diseases, diabetes, hypothyroidism, as well as liver and renal failure.
  • History of systemic use of skin\-related medicine such as glucocorticoids, isotretinoin, immunomodulators and hormonal medicine in the past 3 months
  • Currently pregnant or lactating
  • Smoking in the past two years

Outcomes

Primary Outcomes

Not specified

Similar Trials